CLCS OTC
Cell Source, Inc.
1W: +12.0%
1M: -47.2%
3M: -46.3%
YTD: -6.0%
1Y: +11.9%
3Y: -26.6%
5Y: -6.0%
$0.47
+0.06 (+14.61%)
Weekly Expected Move ±33.2%
$0
$0
$0
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$4M
+11.0% ▲
Net Income
-$5M
+10.3% ▲
EPS (Diluted)
$-0.15
+11.8% ▲
EBITDA
-$4M
+14.6% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $999K | $1M | $2M | $2M | $2M |
| SG&A Expenses | $3M | $3M | $2M | $3M | $2M |
| Operating Expenses | $4M | $4M | $4M | $4M | $4M |
| Operating Income | -$4M | -$4M | -$4M | -$4M | -$4M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $937K | $1M | $992K | $1M | $1M |
| Income Before Tax | -$5M | -$5M | -$5M | -$5M | -$5M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$5M | -$5M | -$5M | -$5M | -$5M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.19 | $-0.19 | $-0.18 | $-0.17 | $-0.15 |
| EBITDA | -$4M | -$93K | $0 | -$4M | -$4M |
| Shares Outstanding | 29M | 33M | 35M | 38M | 42M |